Cardiovascular & Hematological Disorders-Drug Targets
Title:Meet Our Associate Editorial Board Member
Volume: 20 Issue: 2
Author(s): Chengfeng Bi
Affiliation:
Export Options
About this article
Cite this article as:
Bi Chengfeng , Meet Our Associate Editorial Board Member, Cardiovascular & Hematological Disorders-Drug Targets 2020; 20 (2) . https://dx.doi.org/10.2174/1871529X2002200428121739
DOI https://dx.doi.org/10.2174/1871529X2002200428121739 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
26
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Secondary Stroke Prevention with Antithrombotic Drugs
Current Vascular Pharmacology β-Adrenomimetic Actions in the Hypotension and Vasodilatation Induced by a Chromatographic Active Fraction from Bidens pilosa L. (Asteraceae) in Mammals
Current Bioactive Compounds Experience with Multiplex ARMS (MARMS)-PCR for the Detection of Common βThalassemia Mutations in India
Cardiovascular & Hematological Agents in Medicinal Chemistry Imaging Paradigms in Nontraumatic Aortic Emergencies
Current Medical Imaging Pexelizumab and its Role in the Treatment of Myocardial Infarction and in Coronary Artery Bypass Graft Surgery: A Review
Recent Patents on Cardiovascular Drug Discovery Allosteric Inhibitors of Hepatitis C NS5B RNA-dependent RNA Polymerase°
Current Medicinal Chemistry - Anti-Infective Agents The Oxidative Stress Menace to Coronary Vasculature: Any Place for Antioxidants?
Current Pharmaceutical Design Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis
Current Drug Targets A Cyclooxygenase-2 Inhibitor Reduces Vascular Wall Thickness and Ameliorates Cognitive Impairment in a Cerebral Small Vessel Diseases Rat Model
Current Alzheimer Research Promising Anti-Fibrotic Approaches for Future Treatment of Systemic Sclerosis
Current Rheumatology Reviews Diabetes Mellitus and Acute Coronary Syndrome: A Lethal Combination Requiring Better Therapeutic Strategies
Current Vascular Pharmacology Therapeutic Strategy of Erythropoietin in Neurological Disorders
CNS & Neurological Disorders - Drug Targets The Protective Role of Crocus Sativus L. (Saffron) Against Ischemia- Reperfusion Injury, Hyperlipidemia and Atherosclerosis: Nature Opposing Cardiovascular Diseases
Current Cardiology Reviews Research Progress in Pharmacological Mechanisms, Structure-Activity Relationship and Synthesis of Sartans
Current Medicinal Chemistry Improvement of Nutritional Qualities of Fermented Kernels of Wild Legume Canavalia cathartica by Rhizopus oligosporus
Current Biochemical Engineering (Discontinued) Therapeutic Approach to Patients with Heart Failure with Reduced Ejection Fraction and End-stage Renal Disease
Current Cardiology Reviews Nutrigenetics of the Postprandial Lipoprotein Metabolism: Evidences From Human Intervention Studies
Current Vascular Pharmacology Cardiovascular Disease in Primary Sjögren’s Syndrome
Reviews on Recent Clinical Trials Gliogenesis and Glial Pathology in Depression
CNS & Neurological Disorders - Drug Targets Protein disulfide isomerase and Nox: new partners in redox signaling
Current Pharmaceutical Design